{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Stable extended release oral dosage composition comprising loratadine and pseudoephedrine", "item": "https://www.patentleaderboard.com/patent/5314697"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Stable extended release oral dosage composition comprising loratadine and pseudoephedrine

Stable extended release oral dosage composition comprising loratadine and pseudoephedrine

US Patent 5314697 · Granted May 24, 1994

Estimated economic value: $73,342,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compostions comprising viruses and methods for concentrating virus preparations2003
Orally administrable solid ribavirin dosage forms and process for making them2002
Orally administrable solid dosage form2002
Orally administrable solid dosage form2000
Process of making solid ribavirin dosage forms1999
Orally administrable solid dosage form1999
Biologically stable interferon compositions comprising thimerosal1989
Sustained release dosage form1988
Biologically stable alpha-interferon formulations1985